Subtle Neurological Manifestations With Unexpected Lesion Extension After High-Dose Methylprednisolone in Neuromyelitis Optica Spectrum Disorder. [PDF]
Yamada G, Okita K, Kuno T, Katada E.
europepmc +1 more source
Diagnostic Challenges and Clinical Management of Area Postrema Syndrome: A Case Report on Persistent Nausea and Vomiting. [PDF]
Manole AG +4 more
europepmc +1 more source
The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications. [PDF]
Liu Y, Hasseldam H.
europepmc +1 more source
Prevalence and risk factors of bipolar disorder in central nervous system autoimmune demyelinating diseases. [PDF]
Mirmosayyeb O +5 more
europepmc +1 more source
Comparison of clinical and laboratory characteristics of neuromyelitis optica spectrum disorder with or without anti-connective tissue antibodies: an 18-month cohort follow-up. [PDF]
Shi S +7 more
europepmc +1 more source
Health-related quality of life and its associated factors among patients with neuromyelitis optica spectrum disorder in China: a questionnaire survey analysis. [PDF]
Jiang W, Yan S, Xie S, Wu J.
europepmc +1 more source
Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. [PDF]
Kittipadakul S +6 more
europepmc +1 more source
Longitudinal assessment of sNfL and sGFAP in severe NMOSD treated with allogeneic stem cell transplantation. [PDF]
Srpova B +9 more
europepmc +1 more source
Synergistic Interaction Between MALAT1/miR-30b-5p/BAFF Axis and Inflammatory Cytokines Underlies Rituximab-Refractory NMOSD. [PDF]
Deng M +8 more
europepmc +1 more source
Case Report: AQP4-IgG-positive neuromyelitis optica spectrum disorder with CSF anti- NMDAR1 IgG positivity and encephalitic features. [PDF]
Li M, Chen L, Liu Y, Gan T, Guo J.
europepmc +1 more source

